{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:11:01Z","timestamp":1793459461040,"version":"4.5.0"},"reference-count":224,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ocugen Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Inducing humoral and cytotoxic mucosal immunity at the sites of pathogen entry has the potential to prevent the infection from getting established. This is different from systemic vaccination, which protects against the development of systemic symptoms. The field of mucosal vaccination has seen fewer technological advances compared to nucleic acid and subunit vaccine advances for injectable vaccine platforms. The advent of the next-generation adenoviral vectors has given a boost to mucosal vaccine research. Basic research into the mechanisms regulating innate and adaptive mucosal immunity and the discovery of effective and safe mucosal vaccine adjuvants will continue to improve mucosal vaccine design. The results from clinical trials of inhaled COVID-19 vaccines demonstrate their ability to induce the proliferation of cytotoxic T cells and the production of secreted IgA and IgG antibodies locally, unlike intramuscular vaccinations. However, these mucosal vaccines induce systemic immune responses at par with systemic vaccinations. This review summarizes the function of the respiratory mucosa-associated lymphoid tissue and the advantages that the adenoviral vectors provide as inhaled vaccine platforms.<\/jats:p>","DOI":"10.3390\/vaccines11101585","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T03:07:47Z","timestamp":1697080067000},"page":"1585","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens"],"prefix":"10.3390","volume":"11","author":[{"given":"Farokh","family":"Dotiwala","sequence":"first","affiliation":[{"name":"Ocugen Inc., 11 Great Valley Parkway, Malvern, PA 19355, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-1744","authenticated-orcid":false,"given":"Arun K.","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Ocugen Inc., 11 Great Valley Parkway, Malvern, PA 19355, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"809244","DOI":"10.3389\/fimmu.2021.809244","article-title":"SARS-CoV-2 Variants, Vaccines, and Host Immunity","volume":"12","author":"Mistry","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13285","article-title":"Mucosal vaccines and technology","volume":"196","author":"Bentley","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gao, J. (2022). Vaccination with CanSinoBIO\u2019s inhaled COVID-19 vaccine has begun in China. J. Biosaf. Biosecur., 4.","DOI":"10.1016\/j.jobb.2022.12.002"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1063679","DOI":"10.3389\/fimmu.2022.1063679","article-title":"Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)","volume":"13","author":"Sunagar","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Alu, A., Chen, L., Lei, H., Wei, Y., Tian, X., and Wei, X. (2022). Intranasal COVID-19 vaccines: From bench to bed. EBioMedicine, 76.","DOI":"10.1016\/j.ebiom.2022.103841"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121180","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: Factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","article-title":"Mucosal vaccines: Strategies and challenges","volume":"217","author":"Li","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1462-5822.2011.01609.x","article-title":"Optimizing vaccine development","volume":"13","author":"Hoft","year":"2011","journal-title":"Cell. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41577-021-00662-4","article-title":"SARS-CoV-2 breakthrough infections in vaccinated individuals: Measurement, causes and impact","volume":"22","author":"Lipsitch","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 Omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"109400","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.xcrm.2021.100230","article-title":"A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae)","volume":"8","author":"Singh","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Wu, S., Liu, Y., Li, K., Fan, P., Song, X., Wang, Y., Zhao, Z., Zhang, X., and Shang, J. (2022). Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming. medRxiv.","DOI":"10.1101\/2022.03.08.22271816"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S1473-3099(22)00510-2","article-title":"Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990\u20132019: Results from the Global Burden of Disease Study 2019","volume":"22","author":"Collaborators","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/infdis\/jiz321","article-title":"Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction","volume":"221","author":"Lartey","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41385-018-0109-1","article-title":"Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1\u2212 CD4+ T cells","volume":"12","author":"Bull","year":"2019","journal-title":"Mucosal Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(22)02644-7","article-title":"Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: A randomised, double-blind, phase 2b trial","volume":"401","author":"Keech","year":"2023","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1473-3099(20)30274-7","article-title":"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: A phase 1b, double-blind, randomised, placebo-controlled dose-escalation study","volume":"20","author":"Jahnmatz","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41591-022-02162-x","article-title":"Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster","volume":"29","author":"Kurhade","year":"2023","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100644","DOI":"10.1016\/j.lanepe.2023.100644","article-title":"Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines","volume":"29","author":"Boyton","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Antoine","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-381300-8.00007-1","article-title":"Bronchus-associated lymphoid tissue (BALT) structure and function","volume":"107","author":"Randall","year":"2010","journal-title":"Adv. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2019.01323","article-title":"Airway M Cells Arise in the Lower Airway Due to RANKL Signaling and Reside in the Bronchiolar Epithelium Associated With iBALT in Murine Models of Respiratory Disease","volume":"10","author":"Kimura","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Neutra, M. (2005). Cellular and molecular basis for antigen transport across epithelial barriers. Mucosal Immunol., 111\u2013130.","DOI":"10.1016\/B978-012491543-5\/50011-5"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1574-695X.2007.00359.x","article-title":"M-cells: Origin, morphology and role in mucosal immunity and microbial pathogenesis","volume":"52","author":"Corr","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2006.02.015","article-title":"CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer\u2019s patches","volume":"24","author":"Niess","year":"2006","journal-title":"Immunity"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.4049\/jimmunol.179.5.2690","article-title":"Cutting edge: Peyer\u2019s patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: Possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype","volume":"179","author":"Contractor","year":"2007","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1084\/jem.20080414","article-title":"Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans","volume":"205","author":"Jaensson","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.celrep.2018.03.072","article-title":"Manifold Roles of CCR7 and Its Ligands in the Induction and Maintenance of Bronchus-Associated Lymphoid Tissue","volume":"23","author":"Fleige","year":"2018","journal-title":"Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2014.00408","article-title":"The Role of FcRn in Antigen Presentation","volume":"5","author":"Baker","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/immuno2040036","article-title":"Harnessing Nasal Immunity with IgA to Prevent Respiratory Infections","volume":"2","author":"Joseph","year":"2022","journal-title":"Immuno"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro2384","article-title":"The role of secretory antibodies in infection immunity","volume":"8","author":"Strugnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/mi.2017.62","article-title":"The regulation of gut mucosal IgA B-cell responses: Recent developments","volume":"10","author":"Lycke","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e56098","DOI":"10.7554\/eLife.56098","article-title":"The structures of secretory and dimeric immunoglobulin A","volume":"9","author":"Parker","year":"2020","journal-title":"eLife"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/mi.2011.39","article-title":"Structure and function relationships in IgA","volume":"4","author":"Woof","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1016\/j.vaccine.2011.09.010","article-title":"Exploiting mucosal surfaces for the development of mucosal vaccines","volume":"29","author":"Meeusen","year":"2011","journal-title":"Vaccine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/acsinfecdis.9b00109","article-title":"Modeling Barrier Properties of Intestinal Mucus Reinforced with IgG and Secretory IgA against Motile Bacteria","volume":"5","author":"Xu","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.celrep.2018.03.027","article-title":"Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses","volume":"23","author":"Maurer","year":"2018","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1073\/pnas.89.15.6901","article-title":"Intracellular neutralization of virus by immunoglobulin A antibodies","volume":"89","author":"Mazanec","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/jvi.69.2.1339-1343.1995","article-title":"Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies","volume":"69","author":"Mazanec","year":"1995","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11090","DOI":"10.1128\/JVI.00768-11","article-title":"Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization","volume":"85","author":"Zhou","year":"2011","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1128\/JVI.00927-06","article-title":"Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion","volume":"80","author":"Corthesy","year":"2006","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2006.08.006","article-title":"Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells","volume":"356","author":"Wright","year":"2006","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1084\/jem.161.1.198","article-title":"Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG","volume":"161","author":"Taylor","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imcb.12306","article-title":"Serum IgA Fc effector functions in infectious disease and cancer","volume":"98","author":"Davis","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.175.5.2793","article-title":"Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses","volume":"175","author":"Favre","year":"2005","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.autrev.2012.10.011","article-title":"Anti-inflammatory role of the IgA Fc receptor (CD89): From autoimmunity to therapeutic perspectives","volume":"12","author":"Rossato","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/CMR.00090-16","article-title":"The Human Immune Response to Respiratory Syncytial Virus Infection","volume":"30","author":"Russell","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaip.2022.10.002","article-title":"Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19","volume":"11","author":"Ameratunga","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4049\/immunohorizons.2000067","article-title":"Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection","volume":"5","author":"Luangrath","year":"2021","journal-title":"Immunohorizons"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/B978-0-12-396548-6.00008-1","article-title":"Behavior and function of tissue-resident memory T cells","volume":"114","author":"Ariotti","year":"2012","journal-title":"Adv. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20090858","article-title":"Dynamic T cell migration program provides resident memory within intestinal epithelium","volume":"207","author":"Masopust","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.4049\/jimmunol.1200402","article-title":"Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues","volume":"188","author":"Casey","year":"2012","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri3442","article-title":"The integration of T cell migration, differentiation and function","volume":"13","author":"Masopust","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e68662","DOI":"10.7554\/eLife.68662","article-title":"Protective function and durability of mouse lymph node-resident memory CD8+ T cells","volume":"10","author":"Anthony","year":"2021","journal-title":"eLife"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/j.celrep.2018.08.073","article-title":"Repeated Antigen Exposure Extends the Durability of Influenza-Specific Lung-Resident Memory CD8+ T Cells and Heterosubtypic Immunity","volume":"24","author":"Varga","year":"2018","journal-title":"Cell Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1189\/jlb.0313180","article-title":"Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection","volume":"95","author":"Wu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"172ra20","DOI":"10.1126\/scitranslmed.3004888","article-title":"Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors","volume":"5","author":"Sandoval","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri2496","article-title":"Migration, maintenance and recall of memory T cells in peripheral tissues","volume":"9","author":"Woodland","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1039194","DOI":"10.3389\/fimmu.2022.1039194","article-title":"Tissue resident memory T cells\u2014A new benchmark for the induction of vaccine-induced mucosal immunity","volume":"13","author":"Hassert","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41577-023-00853-1","article-title":"Assessing the generation of tissue resident memory T cells by vaccines","volume":"23","author":"Rotrosen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014Fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: Phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13238-012-2927-3","article-title":"CCR10 and its ligands in regulation of epithelial immunity and diseases","volume":"3","author":"Xiong","year":"2012","journal-title":"Protein Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-019-0129-1","article-title":"Successful application of prime and pull strategy for a therapeutic HSV vaccine","volume":"4","author":"Bernstein","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1128\/JVI.03085-12","article-title":"An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice","volume":"87","author":"Im","year":"2013","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00253-012-4575-1","article-title":"Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface","volume":"97","author":"Ribelles","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1080\/22221751.2022.2132881","article-title":"Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants","volume":"11","author":"Zhong","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","article-title":"Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T(RM) cells","volume":"11","author":"Allen","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.2100029","article-title":"Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection","volume":"208","author":"Jong","year":"2022","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Maroof, A., Yorgensen, Y.M., Li, Y., and Evans, J.T. (2014). Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003875"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"eabc5500","DOI":"10.1126\/sciimmunol.abc5500","article-title":"Peyer\u2019s patch TH17 cells are dispensable for gut IgA responses to oral immunization","volume":"7","author":"Gribonika","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2009.02.025","article-title":"Estradiol-induced vaginal mucus inhibits antigen penetration and CD8+ T cell priming in response to intravaginal immunization","volume":"27","author":"Seavey","year":"2009","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4110\/in.2013.13.3.81","article-title":"Sublingual delivery of vaccines for the induction of mucosal immunity","volume":"13","author":"Shim","year":"2013","journal-title":"Immune Netw."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Huo, Z., Bissett, S.L., Giemza, R., Beddows, S., Oeser, C., and Lewis, D.J. (2012). Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033736"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"614115","DOI":"10.3389\/fimmu.2021.614115","article-title":"IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates","volume":"12","author":"Logerot","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-102119-073855","article-title":"Trained Immunity: Reprogramming Innate Immunity in Health and Disease","volume":"39","author":"Bekkering","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained Immunity: A Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/JLB.4MR0220-446R","article-title":"Innate immune memory of tissue-resident macrophages and trained innate immunity: Re-vamping vaccine concept and strategies","volume":"108","author":"Xing","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/mi.2014.11","article-title":"The development and function of mucosal lymphoid tissues: A balancing act with micro-organisms","volume":"7","author":"Randall","year":"2014","journal-title":"Mucosal Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J. Innate Immun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/civ617","article-title":"The effect of oral polio vaccine at birth on infant mortality: A randomized trial","volume":"61","author":"Lund","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_95","first-page":"695","article-title":"Vaccinations against smallpox and tuberculosis are associated with better long-term survival: A Danish case-cohort study 1971\u20132010","volume":"46","author":"Rieckmann","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4049\/jimmunol.1701010","article-title":"Cutting Edge: Plasmodium falciparum Induces Trained Innate Immunity","volume":"200","author":"Schrum","year":"2018","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1038\/ncomms7588","article-title":"Trained immunity in newborn infants of HBV-infected mothers","volume":"6","author":"Hong","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/CVI.00688-13","article-title":"Trained immunity or tolerance: Opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors","volume":"21","author":"Ifrim","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fimmu.2020.00353","article-title":"LXR Activation Induces a Proinflammatory Trained Innate Immunity-Phenotype in Human Monocytes","volume":"11","author":"Sohrabi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans","volume":"134","author":"Bekkering","year":"2016","journal-title":"Circulation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.1620910114","article-title":"Uric acid priming in human monocytes is driven by the AKT\u2013PRAS40 autophagy pathway","volume":"114","author":"Cleophas","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","first-page":"317","article-title":"Aldosterone induces trained immunity: The role of fatty acid synthesis","volume":"116","author":"Keating","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"E9162","DOI":"10.1073\/pnas.1720930115","article-title":"Interferon stimulation creates chromatin marks and establishes transcriptional memory","volume":"115","author":"Kamada","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ni.3745","article-title":"S100-alarmin-induced innate immune programming protects newborn infants from sepsis","volume":"18","author":"Ulas","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCRESAHA.119.315800","article-title":"Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo","volume":"127","author":"Groh","year":"2020","journal-title":"Circ. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41467-019-08659-3","article-title":"Outcomes of controlled human malaria infection after BCG vaccination","volume":"10","author":"Walk","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_108","first-page":"455","article-title":"Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guerin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial","volume":"70","author":"Blok","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-Glucan-Induced Trained Immunity Protects against Leishmania braziliensis Infection: A Crucial Role for IL-32","volume":"28","author":"Cirovic","year":"2019","journal-title":"Cell Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"107634","DOI":"10.1016\/j.celrep.2020.107634","article-title":"\u03b2-Glucan Induces Protective Trained Immunity against Mycobacterium tuberculosis Infection: A Key Role for IL-1","volume":"31","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.4049\/jimmunol.2100107","article-title":"\u03b2-Glucan Induces Distinct and Protective Innate Immune Memory in Differentiated Macrophages","volume":"207","author":"Stothers","year":"2021","journal-title":"J. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41423-023-01017-w","article-title":"A novel role for mitochondrial fission in macrophages: Trained innate immunity induced by beta-glucan","volume":"20","author":"Brichkina","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-11-14","article-title":"Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection","volume":"11","author":"Ribes","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"583077","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging Concepts and Technologies in Vaccine Development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: Design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"611337","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1128\/JVI.00207-09","article-title":"Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge","volume":"83","author":"Perrone","year":"2009","journal-title":"J. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.166.5.3451","article-title":"Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract","volume":"166","author":"Gallichan","year":"2001","journal-title":"J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/dna.1993.12.771","article-title":"Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene","volume":"12","author":"Yankauckas","year":"1993","journal-title":"DNA Cell Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/acsbiomaterials.6b00418","article-title":"Polymers for DNA Vaccine Delivery","volume":"3","author":"Zhang","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2021.01.014","article-title":"Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic","volume":"331","author":"Yun","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Li, Y.D., Chi, W.Y., Su, J.H., Ferrall, L., Hung, C.F., and Wu, T.C. (2020). Coronavirus vaccine development: From SARS and MERS to COVID-19. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-00695-2"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41541-022-00485-x","article-title":"Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies","volume":"7","author":"Hameed","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: Historical successes and current challenges","volume":"479\u2013480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.biotechadv.2015.05.010","article-title":"Nanoengineering of vaccines using natural polysaccharides","volume":"33","author":"Cordeiro","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"De Serrano, L.O., and Burkhart, D.J. (2017). Liposomal vaccine formulations as prophylactic agents: Design considerations for modern vaccines. J. Nanobiotechnol., 15.","DOI":"10.1186\/s12951-017-0319-9"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.2174\/1381612822666160915161302","article-title":"An Updated Review of ISCOMSTM and ISCOMATRIXTM Vaccines","volume":"22","author":"Garcia","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/21645515.2015.1009345","article-title":"Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases","volume":"11","author":"Lin","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2016.06.013","article-title":"Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering","volume":"110\u2013111","author":"Eskandari","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/erv.10.172","article-title":"Proteosome-adjuvanted intranasal influenza vaccines: Advantages, progress and future considerations","volume":"10","author":"Burt","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: From 1920 to 2015 and Beyond","volume":"3","author":"Preiss","year":"2015","journal-title":"Vaccines"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.7150\/thno.70853","article-title":"Advances in the polymeric delivery of nucleic acid vaccines","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.addr.2013.05.002","article-title":"Polysaccharide-based nucleic acid nanoformulations","volume":"65","author":"Raemdonck","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Thompson, M., and Scholz, C. (2021). Highly Branched Polymers Based on Poly(amino acid)s for Biomedical Application. Nanomaterials, 11.","DOI":"10.3390\/nano11051119"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Wibowo, D., Jorritsma, S.H.T., Gonzaga, Z.J., Evert, B., Chen, S., and Rehm, B.H.A. (2021). Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials, 268.","DOI":"10.1016\/j.biomaterials.2020.120597"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Niza, E., Oca\u00f1a, A., Castro-Osma, J.A., Bravo, I., and Alonso-Moreno, C. (2021). Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment. Cancers, 13.","DOI":"10.3390\/cancers13143387"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"11647","DOI":"10.1002\/anie.201501461","article-title":"Self-Assembled Fluorodendrimers Combine the Features of Lipid and Polymeric Vectors in Gene Delivery","volume":"54","author":"Wang","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.addr.2013.04.001","article-title":"Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors","volume":"65","author":"Arima","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.nano.2017.05.011","article-title":"Polyethylene glycol modified PAMAM dendrimer delivery of kartogenin to induce chondrogenic differentiation of mesenchymal stem cells","volume":"13","author":"Hu","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2020.02.056","article-title":"A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates","volume":"38","author":"Mueller","year":"2020","journal-title":"Vaccine"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e2102775118","DOI":"10.1073\/pnas.2102775118","article-title":"Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","article-title":"Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses","volume":"31","author":"Morens","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Czerkinsky, C., and Holmgren, J. (2015). Vaccines against enteric infections for the developing world. Philos. Trans. R. Soc. Lond. B Biol. Sci., 370.","DOI":"10.1098\/rstb.2015.0142"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cid\/cix869","article-title":"2015\u20132016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States","volume":"66","author":"Poehling","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41385-020-0309-3","article-title":"Long-term maintenance of lung resident memory T cells is mediated by persistent antigen","volume":"14","author":"Cartwright","year":"2021","journal-title":"Mucosal Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2213-2600(23)00049-8","article-title":"Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: A multicentre, open-label, phase 4, randomised trial","volume":"11","author":"Tang","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_150","unstructured":"Mestecky, J., Strober, W., Russell, M.W., Kelsall, B.L., Cheroutre, H., and Lambrecht, B.N. (2015). Mucosal Immunology, Academic Press."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e2202069119","DOI":"10.1073\/pnas.2202069119","article-title":"Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection","volume":"119","author":"Americo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/jiac129","article-title":"Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses","volume":"226","author":"Li","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"13916","DOI":"10.1038\/ncomms13916","article-title":"A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation","volume":"7","author":"Stobart","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.chom.2020.12.010","article-title":"Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models","volume":"29","author":"Ku","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Koonpaew, S., Kaewborisuth, C., Srisutthisamphan, K., Wanitchang, A., Thaweerattanasinp, T., Saenboonrueng, J., Poonsuk, S., Jengarn, J., Viriyakitkosol, R., and Kramyu, J. (2021). A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model. Vaccines, 9.","DOI":"10.3390\/vaccines9080850"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"103379","DOI":"10.1016\/j.isci.2021.103379","article-title":"Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2","volume":"24","author":"Ohtsuka","year":"2021","journal-title":"iScience"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41467-021-26499-y","article-title":"A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"577823","DOI":"10.3389\/fimmu.2020.577823","article-title":"MPL Adjuvant Contains Competitive Antagonists of Human TLR4","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: Helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_161","first-page":"465","article-title":"AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix(R)): A review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000049504","article-title":"A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines","volume":"126","author":"Wheeler","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1021\/acs.molpharmaceut.0c01256","article-title":"Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity","volume":"18","author":"Bakkari","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jconrel.2022.05.023","article-title":"Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine","volume":"347","author":"Atalis","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"19874","DOI":"10.1074\/jbc.RA118.002768","article-title":"A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice","volume":"293","author":"Tandon","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/21505594.2022.2068489","article-title":"Vaccination inducing durable and robust antigen-specific Th1\/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease","volume":"13","author":"Lee","year":"2022","journal-title":"Virulence"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Arias, M.A., Van Roey, G.A., Tregoning, J.S., Moutaftsi, M., Coler, R.N., Windish, H.P., Reed, S.G., Carter, D., and Shattock, R.J. (2012). Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041144"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12985-021-01672-3","article-title":"A formulated poly (I:C)\/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine","volume":"18","author":"Sabbaghi","year":"2021","journal-title":"Virol. J."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"McNally, B., Willette, M., Ye, F., Partida-Sanchez, S., and Flano, E. (2012). Intranasal administration of dsRNA analog poly(I:C) induces interferon-alpha receptor-dependent accumulation of antigen experienced T cells in the airways. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051351"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"109401","DOI":"10.1016\/j.celrep.2021.109401","article-title":"A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant","volume":"36","author":"Zhao","year":"2021","journal-title":"Cell Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2011.10.058","article-title":"Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection","volume":"30","author":"Hong","year":"2012","journal-title":"Vaccine"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.27147","article-title":"TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines","volume":"10","author":"Hjelm","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"672143","DOI":"10.3389\/fimmu.2021.672143","article-title":"TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice","volume":"12","author":"Cheng","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Griffiths, K.L., Stylianou, E., Poyntz, H.C., Betts, G.J., Fletcher, H.A., and McShane, H. (2013). Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078312"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Lewis, D.J., Huo, Z., Barnett, S., Kromann, I., Giemza, R., Galiza, E., Woodrow, M., Thierry-Carstensen, B., Andersen, P., and Novicki, D. (2009). Transient facial nerve paralysis (Bell\u2019s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006999"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e00215-18","DOI":"10.1128\/mSphere.00215-18","article-title":"The Mucosal Vaccine Adjuvant LT(R192G\/L211A) or dmLT","volume":"3","author":"Clements","year":"2018","journal-title":"mSphere"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J. Immunol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3389\/fimmu.2019.01126","article-title":"alpha-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1016\/j.vaccine.2007.04.081","article-title":"A single intranasal immunization with inactivated influenza virus and \u03b1-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system","volume":"25","author":"Youn","year":"2007","journal-title":"Vaccine"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.vaccine.2009.03.090","article-title":"Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine","volume":"27","author":"Fraser","year":"2009","journal-title":"Vaccine"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Gong, X., Gao, Y., Shu, J., Zhang, C., and Zhao, K. (2022). Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines. Vaccines, 10.","DOI":"10.3390\/vaccines10111906"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4161\/hv.27449","article-title":"Chitosan: A promising safe and immune-enhancing adjuvant for intranasal vaccines","volume":"10","author":"Smith","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biologicals.2017.10.004","article-title":"Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles","volume":"51","author":"Mohamed","year":"2018","journal-title":"Biologicals"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"52691","DOI":"10.1021\/acsami.2c17627","article-title":"Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery","volume":"14","author":"Lin","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Renu, S., and Renukaradhya, G.J. (2020). Chitosan Nanoparticle Based Mucosal Vaccines Delivered Against Infectious Diseases of Poultry and Pigs. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.558349"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.1214935","article-title":"Disease tolerance as a defense strategy","volume":"335","author":"Medzhitov","year":"2012","journal-title":"Science"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri.2016.117","article-title":"Early local immune defences in the respiratory tract","volume":"17","author":"Iwasaki","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41385-021-00470-y","article-title":"Redefining intestinal immunity with single-cell transcriptomics","volume":"15","author":"James","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"24448","DOI":"10.1038\/s41598-021-03931-3","article-title":"Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination","volume":"11","author":"Mades","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"eabo2523","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41392-023-01423-6","article-title":"Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nri3739","article-title":"The role of airway epithelial cells and innate immune cells in chronic respiratory disease","volume":"14","author":"Holtzman","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ni.3045","article-title":"Respiratory epithelial cells orchestrate pulmonary innate immunity","volume":"16","author":"Whitsett","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00018-018-2976-8","article-title":"The inflammatory function of human IgA","volume":"76","author":"Hansen","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Gould, V.M.W., Francis, J.N., Anderson, K.J., Georges, B., Cope, A.V., and Tregoning, J.S. (2017). Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00900"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1016\/j.vaccine.2018.04.066","article-title":"The influence of the intestinal microbiome on vaccine responses","volume":"36","author":"Zimmermann","year":"2018","journal-title":"Vaccine"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.celrep.2019.05.105","article-title":"Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection","volume":"28","author":"Bradley","year":"2019","journal-title":"Cell Rep."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e170682","DOI":"10.1172\/JCI170682","article-title":"Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19","volume":"133","author":"Gao","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5603\/ARM.a2021.0036","article-title":"Predictors of mortality in patients with severe COVID-19 pneumonia\u2014A retrospective study","volume":"89","author":"Mahendra","year":"2021","journal-title":"Adv. Respir. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1002\/hsr2.428","article-title":"Respiratory syncytial virus-associated deaths in the United States according to death certificate data, 2005 to 2016","volume":"4","author":"Prill","year":"2021","journal-title":"Health Sci. Rep."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J. Immunol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/imr.13118","article-title":"Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection","volume":"309","author":"Sanders","year":"2022","journal-title":"Immunol. Rev."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.3389\/fimmu.2018.02936","article-title":"Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations","volume":"9","author":"Conejero","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","article-title":"Risks Associated With Lentiviral Vector Exposures and Prevention Strategies","volume":"58","author":"Schlimgen","year":"2016","journal-title":"J. Occup. Environ. Med."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"849515","DOI":"10.3389\/fimmu.2022.849515","article-title":"Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back","volume":"13","author":"Chentoufi","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1473-3099(23)00350-X","article-title":"Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: A multicentre, open-label phase 3 trial","volume":"23","author":"Li","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/mtm.2016.30","article-title":"Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens","volume":"3","author":"Afkhami","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMc2210813","article-title":"Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine","volume":"387","author":"Lane","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.2022017696","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"141","author":"Cines","year":"2023","journal-title":"Blood"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/jth.15485","article-title":"To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia","volume":"19","author":"Othman","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<360::AID-JGM54>3.0.CO;2-Q","article-title":"Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits","volume":"1","author":"Cichon","year":"1999","journal-title":"J. Gene Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood.2021014712","article-title":"Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration","volume":"140","author":"Nicolai","year":"2022","journal-title":"Blood"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"eabl8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2022.02.004","article-title":"Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"59","author":"Greinacher","year":"2022","journal-title":"Semin. Hematol."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Al-Nemrawi, N.K., Darweesh, R.S., Al-Shriem, L.A., Al-Qawasmi, F.S., Emran, S.O., Khafajah, A.S., and Abu-Dalo, M.A. (2022). Polymeric Nanoparticles for Inhaled Vaccines. Polymer, 14.","DOI":"10.3390\/polym14204450"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"21501327211007393","DOI":"10.1177\/21501327211007393","article-title":"Considering Needle Phobia among Adult Patients During Mass COVID-19 Vaccinations","volume":"12","author":"Love","year":"2021","journal-title":"J. Prim. Care Community Health"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"860399","DOI":"10.3389\/fimmu.2022.860399","article-title":"Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes","volume":"13","author":"Jeyanathan","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/10\/1585\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:23Z","timestamp":1760130323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/10\/1585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":224,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["vaccines11101585"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11101585","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]}}}